Hikal 

₹222.30
18
-₹18.06-7.51% Friday 09:59

統計

當日最高
236.74
當日最低
220.1
52週高點
282.7
52週低點
146.25
成交量
5,351,852
平均成交量
874,606
市值
27.45B
本益比
-
股息殖利率
0.27%
股息
0.6

即將到來

股息

0.27%股息殖利率
Mar 26
₹0.20
Sep 25
₹0.80
Mar 25
₹0.60
Sep 24
₹0.60
Mar 24
₹0.60
10年成長
-11.34%
5年成長
-3.58%
3年成長
不適用
1年成長
-16.67%

財報

11Nov預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
下一步
-2.8
-0.47
1.85
4.17
預期EPS
不適用
實際EPS
不適用

財務

-4.45%利潤率
未盈利
2020
2021
2022
2023
2024
2025
23.83B營收
-1.06B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 HIKAL.NSE 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Show more...
執行長
Sameer Hiremath
員工
3595
國家
印度
ISIN
INE475B01022

上市

0 Comments

分享你的想法

FAQ

Hikal 今天的股價是多少?
HIKAL.NSE 目前價格為 ₹222.30 INR,過去 24 小時下跌了 -7.51%。在圖表上更密切關注 Hikal 股票的表現。
Hikal 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 NSE (India) 交易所,Hikal 的股票以代號 HIKAL.NSE 進行交易。
Hikal 的股價在上漲嗎?
HIKAL.NSE 股票較上週上漲 +8.89%,本月下跌 -4.59%,過去一年 Hikal 下跌 -15.19%。
Hikal 的市值是多少?
今天 Hikal 的市值為 27.45B
Hikal 下一次財報日期是什麼時候?
Hikal 將於 November 11, 2026 公布下一次財報。
Hikal 上一季度的財報如何?
HIKAL.NSE 上一季度的財報為每股 -1.31 INR,預估為 不適用 INR,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 INR。
Hikal 去年的營收是多少?
Hikal 去年的營收為 23.83BINR。
Hikal 去年的淨利是多少?
HIKAL.NSE 去年的淨收益為 -1.06BINR。
Hikal 會發放股息嗎?
是的,HIKAL.NSE 的股息每 半年一次 發放一次。每股最新股息為 0.2 INR。截至今日,股息殖利率(FWD)% 為 0.27%。
Hikal 有多少名員工?
截至 September 05, 2026,公司共有 3,595 名員工。
Hikal 位於哪個產業?
Hikal從事於Health & Wellness產業。
Hikal 何時完成拆股?
Hikal 上次拆股發生於 June 22, 2018,比例為 3:2。
Hikal 的總部在哪裡?
Hikal 的總部位於 印度 的 Navi Mumbai。